Difference in the lipid nanoparticle technology employed in three approved siRNA (Patisiran) and mRNA (COVID-19 vaccine) drugs - Suzuki, Yuta; Ishihara, Hiroshi (Drug metabolism and pharmacokinetics, 2021)
Keywords: Animals; COVID-19; COVID-19 - immunology; COVID-19 vaccine moderna; COVID-19 Vaccines - immunology; Elasomeran; Humans; Ionizable lipid; Lipid nanoparticles; Liposomes - immunology; LNP; mRNA vaccine; mRNA Vaccines - immunology; Nanoparticles; Patisiran; Review; RNA, Small Interfering - immunology; SARS-CoV-2; Technology - methods; Tozinameran; Vaccines, Synthetic - immunology; COVID-19; SARS-CoV-2; Elasomeran; Tozinameran; Patisiran; Ionizable lipid; COVID-19 vaccine moderna; Lipid nanoparticles; LNP; mRNA vaccine